CIK 0001651308
- Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981209416
- Phone
- +41 616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale CMO, Hematology sold 2,500 shares at an average $130.07 ($325,168)
- 4 Open-market sale CFO & Chief Strategy Officer sold 23,200 shares at $130.21 ($3,020,860)
- 4 Open-market sale Director sold 15,027 shares at $125.11 ($1,880,028)
- 4 Open-market sale CFO & Chief Strategy Officer sold 1,800 shares at $130.01 ($234,014)
- 4 Open-market sale President & GM China sold 5,955 shares at an average $124.52 ($741,546)
- 4 Open-market sale Chief Executive Officer sold 2,824 shares at an average $125.18 ($353,505)
- 4 Open-market sale CMO, Hematology sold 14,130 shares at an average $142.77 ($2,017,315)
- 4 Open-market sale Director sold 14,973 shares at $136.10 ($2,037,825)
- 4 Gift Director gave 20,969 shares (gift)
- 4 Open-market sale CMO, Hematology sold 2,636 shares at an average $130.28 ($343,426)
- 4 Open-market sale Chief Executive Officer sold 25,499 shares at an average $151.73 ($3,868,938)
- 4 Open-market sale Director sold 5,000 shares at an average $146.82 ($734,125)
- 4 Open-market sale CMO, Immuno-oncology sold 20,000 shares at an average $133.68 ($2,673,536)
- 4 Open-market sale Chief Executive Officer sold 4,138 shares at an average $135.78 ($561,863)
- 4 Open-market sale Director sold 5,000 shares at an average $152.41 ($762,061)
- 4 Open-market sale Chief Executive Officer sold 29,195 shares at an average $143.66 ($4,194,035)
Page 23 of 29 · 580 filings